Price
CHART BY
Historical dividends and forecast
Thermo Fisher has so far distributed $0.90 in 2026. The next dividend will be paid on 15.07.2026
CHART BY
Frequently asked questions
What is Thermo Fisher's market capitalization?
What is Thermo Fisher's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Thermo Fisher?
What are the analyst ratings and target price for Thermo Fisher's stock?
What is Thermo Fisher's revenue over the trailing twelve months?
Is Thermo Fisher paying dividends?
What is the EBITDA for Thermo Fisher?
What is the free cash flow of Thermo Fisher?
How many employees does Thermo Fisher have, and what sector and industry does it belong to?
What is the free float of Thermo Fisher's shares?
Financials
- Market Cap
- $190.65B
- EPS (TTM)
- $18.19
- Free Float
- 370.74M
- P/E ratio (TTM)
- 28.21
- Revenue (TTM)
- $45.20B
- EBITDA (TTM)
- $11.34B
- Free Cashflow (TTM)
- $6.75B
Pricing
- 1D span
- $513.04$514.22
- 52W span
- $401.72$643.80
Analyst Ratings
The price target is $595.21 and the stock is covered by 31 analysts.
Buy
25
Hold
6
Sell
0
Information
Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.
- Employees
- 125,000
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- TMO
